|
Match
|
Document |
Document Title |
|
|
US20110123517 |
DISSOLVABLE PHARMACEUTICAL IMPLANT
A pharmaceutical implant may include a pharmaceutical and at least one excipient, and may be configured to be implanted in a body of a patient. The at least one excipient may dissolve after... |
|
|
US20110015134 |
Method of treatment for early stage cancer
This patent describes a method and materials to treat cancer diagnosed at an early stage, particularly breast cancer. It considers that metastatic breast cancer growth includes periods of... |
|
|
US20150141386 |
USE OF VITAMIN K TO DECREASE ALLOGRAFT FAILURE AND PATIENT MORTALITY AFTER ORGAN TRANSPLANTATION
Poor vitamin K status is provided as an independent risk factor for allograft failure and mortality in patients who received organ transplantation and who are under immunosuppressive medication.... |
|
|
US20150164824 |
METHODS AND COMPOSITIONS USEFUL FOR IMPROVING BONE AND JOINT HEALTH
Compositions for improving bone health, joint health, or both in an individual in need thereof are provided, along with methods of using the compositions. Generally, the compositions include a... |
|
|
US20130324503 |
Method of identifying and treating a person having a predisposition to or afflicted with Parkinson disease
The present invention relates to methods of treatment for Parkinson Disease (PD) in a person by identifying gene variants which may indicate a more favorable response to specific medicaments,... |
|
|
US20130345312 |
TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES
Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic... |
|
|
US20150250726 |
Nanoscale Bound Bilayers, Methods of Use and Production
Methods for rapidly obtaining a nanoscale apolipoprotein bound phospholipid bilayer (NABB) associated with at least one membrane protein are provided. Also disclosed are methods for rapidly... |
|
|
US20140186329 |
POLYPHENOL ANALOGS TO TREAT ISCHEMIA
The present invention provides methods of use of polyphenol compounds for treating, preventing, mitigating and delaying ischemia or a condition where ischemia occurs. In one embodiment, the method... |
|
|
US20130237610 |
DYNAMIC BALANCING OF AUTONOMIC NERVOUS SYSTEM THROUGH VITAMIN MK-7
Sympathovagal balance is essential in maintaining internal homeostasis. Imbalance in this can lead to many disease conditions such as cardiovascular diseases, type 2 diabetes mellitus, high blood... |
|
|
US20120264765 |
Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis
The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral... |
|
|
US20090239952 |
VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
The invention provides methods and compositions tor treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (BGKR) therapy, where the method comprises applying a... |
|
|
US20110158983 |
COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
In alternative embodiments, this invention provides compositions and methods for treating cancer or any condition caused by dysfunctional cells, side effects from treatments for cancer or any... |
|
|
US20130172423 |
VITAMIN CONTAINING PRODUCT
A food product comprising menaquinone at a level of 50 to 5,000 μg per 100 g of product. |
|
|
US20100297251 |
ENCAPSULATED PARTICLES FOR ENTERIC RELEASE
The present invention provides a system for delivery of an enteric coated active agent generally resistant to disintegration in an neutral environment having one or more active agents encapsulated... |
|
|
US20110087152 |
FLUIDIC TISSUE AUGMENTATION COMPOSITIONS AND METHODS
Compositions and method for augmenting tissue after delivery to localized area. The compositions include a hydrogel and a dermal filler. The hydrogel can polymerize and/or crosslink upon a first... |
|
|
US20100330159 |
System for transporting active substances in a biological system
A stabilizer-free system for transporting active substances in a biological system of one or more active substances and magnetic particles, which is characterized in that the particles are... |
|
|
US20140105959 |
METHOD AND DEVICE FOR REDUCING DERMAL FILLER ADVERSE EVENTS
Methods and devices of aesthetically enhancing and improving appearance of aging skin are provided. Methods may include the steps of treating a skin site selected for dermal filler administration... |
|
|
US20090136592 |
Vitamin preparation
Two-phase preparation for temporally gradual administration comprising a) a phase (A) comprising water soluble vitamins and/or the corresponding provitamins, wherein phase (A) does not contain... |
|
|
US20070043110 |
Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins
A combination of Vitamin C and a quinone used as a supplemental treatment for an ovarian cancer patient. The combination may be administered before, during and after the patient undergoes a... |
|
|
US20120309846 |
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING MYELODYSPLASTIC SYNDROME
The invention encompasses dosing regimens in which a subject is administered menatetrenone over a period of time to establish initial therapeutic baseline blood concentration of the menatetrenone... |
|
|
US20110091387 |
METHODS AND COMPOSITIONS FOR REDUCING SKIN DAMAGE
The RhoE GTPase pathway has been identified as a target for screening and treatment methods for the prevention and/or reduction of short- and long-term UVB-induced skin damage, e.g., the... |
|
|
US20120309847 |
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING PROMYELOCYTIC LEUKEMIA
The invention encompasses dosing regimens in which a subject is administered menatetrenone over a period of time to establish initial therapeutic baseline blood concentration of the menatetrenone... |
|
|
US20120309744 |
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING HEPATOCELLULAR CARCINOMA
The invention encompasses dosing regimens in which a subject is administered menatetrenone over a period of time to establish initial therapeutic baseline blood concentration of the menatetrenone... |
|
|
US20130030050 |
TREATMENT OF OSTEOPOROSIS
According to the invention there is provided a compound of formula (I): wherein R1, R2, R3 and n have meanings given in the description, or a pharmaceutically acceptable solvate, salt or prodrug... |
|
|
US20120100077 |
MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION
Disclosed is a mixture of amphipathic molecules and a method for modifying cells in vivo by way of membrane fusion with these molecules. |
|
|
US20100099776 |
OILY SUSPENSION OF ATOVAQUONE
The present invention relates to an oily suspension of atovaquone comprising atovaquone particles and a combination of surfactants having HLB more than 10. |
|
|
US20100029784 |
NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES
The present invention relates to methods and compositions comprising naphthoquinones such as 2,3-dimethylnaphthalene-1,4-dione, for the use of treating, regulating or preventing a skin condition... |
|
|
US20110064803 |
NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2
The present invention is directed to compositions comprising a nanoparticulate vitamin K2 having improved bioavailability. The nanoparticulate vitamin K2 particles of the composition have an... |
|
|
US20100034878 |
COMBINATION OF VITAMIN K AND VITAMIN K ANTAGONIST SUCH AS R-ISOMER OF WARFARIN, PHENPROCOUMON OR R-ISOMER OF PHENPROCOUMON AS ANTICOAGULANT THERAPY
Medications which are derived by combining one or more doses of the agonist, vitamin K, with doses of one or more selected vitamin K antagonists such as the R-isomer of warfarin, the R-isomer of... |
|
|
US20140162987 |
Solid Solution Compositions and Use in Severe Pain
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a severe pain in an individual using such... |
|
|
US20060275909 |
Nutrition formulations and methods of providing nutrition formulations
Nutritional compositions such as total parenteral nutrition (TPN) compositions and processes of preparing same are disclosed. The advantage of the present invention lies in its ability to tailor... |
|
|
US20080199534 |
Stability in vitamin and mineral supplements
The invention provides a multivitamin and mineral nutritional supplement composition comprising at least one polyvalent metal and at least one oxidizable vitamin with substantially improved... |
|
|
US20060275237 |
Skin care compositions containing idebenone
A stable skin care composition, comprising an effective amount of idebenone, at least one additional skin care active, and a dermatologically acceptable carrier. |
|
|
US20060078530 |
Using high-density grapes to rejuvenate human skin
The present invention provides a method for rejuvenating the skin by applying a chemical system that stimulates the skin to repair and build itself naturally at the same time the chemical system... |
|
|
US20150239859 |
PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN
Peripherally acting cannabinoid agonist compounds, pharmaceutical compositions, and methods of using them are presented. |
|
|
US20130096175 |
Compounds and Methods for Altering Lifespan of Eukaryotic Organisms
Provided are compounds which generally have a triketone structure. Examples of the compounds include derivatives of 1,3-cyclohexanedione, such as: 1,3-cyclohexanedione, 2-propanoyl-5-cyclohexyl-;... |
|
|
US20110002905 |
COMPOSITIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS CONTAINING PROTEIN-POLYSACCHARIDE CONJUGATES
The present invention relates to compositions containing one or more proteins, one or more polysaccharides and one or more fat-soluble active ingredients and their use for the enrichment,... |
|
|
US20060127499 |
Vitamin-mineral compositions
This invention provides compositions of vitamins and minerals used in the prevention and treatment of vitamin and mineral deficiency. These compositions provide a minimization of the intake dosage... |
|
|
US20100247632 |
STABILIZED SOLUBILITY-ENHANCED FORMULATIONS FOR ORAL DELIVERY
Methods and compositions are described whereby poorly water-soluble beneficial agents such as vitamins and co-factors are formulated into self-emulsifying formulas (SEF) and optionally sorbing the... |
|
|
US20070287755 |
Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency
The present invention relates to an orally administered compound, for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin deficiency, comprising K1 vitamin, in an oil solution,... |
|
|
US20140199372 |
MICROBIAL GROWTH FACTORS
Disclosed are methods of cultivating or isolating a microorganism using one or more quinones as growth factors. Also disclosed are methods of treating a mammalian species with deficiency in... |
|
|
US20110305758 |
ORALLY DISINTEGRATING TABLET HAVING INNER CORE
The present invention provides an orally disintegrating tablet with improved photostability of a medicament unstable to light. The orally disintegrating tablet has an inner core and an outer layer... |
|
|
US20110059911 |
Antiinfective and Antitumoral Compounds Isolated From Tropical Lianas
The present invention relates to naphthoquinone derivatives isolated from solid callus cultures from two species of the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. It... |
|
|
US20110045089 |
VITAMIN K3 DERIVATIVE / NSA FORMULATION
The present invention discloses highly stabilized nicotinamide (NA) formulated vitamin K3 derivative particles, whereby the NA forms a physical protective layer (both continuous and discontinuous)... |
|
|
US20120010176 |
UTROPHIN PROMOTER ACTIVITY UPREGULATION FOR THE TREATMENT OF MUSCULAR DYSTROPHY
Methods are provided for increasing utrophin promoter activity, utrophin expression or utrophin activity, and treating or reducing the symptoms of muscular dystrophy by administering to a subject... |
|
|
US20060293395 |
Methods for treating a mammal before, during and after cardiac arrest
Methods for treating mammals before, during and after cardiac arrest are disclosed. Pharmaceutical compositions comprising levosimendan useful for such treatment also are disclosed. |
|
|
US20140336268 |
FORMULATIONS OF VITAMIN K ANALOGS FOR TOPICAL USE
The present invention provides topical formulations containing a vitamin K analog, e.g., menadione, that deliver a uniform, therapeutically effective concentration of the vitamin K analog to the... |
|
|
US20130225690 |
VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a... |
|
|
US20100324148 |
VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a... |
|
|
US20120009169 |
SELF-FORMING PHOSPHOLIPIDIC GELS
A phospholipid gel is spontaneously formed when combining a first phospholipid, a second phospholipid, and water, wherein the first phospholipid is a neutral phospholipid and the second... |